These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 21749855
1. Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: insight into the ganglioside binding mechanism. Nuemket N, Tanaka Y, Tsukamoto K, Tsuji T, Nakamura K, Kozaki S, Yao M, Tanaka I. Biochem Biophys Res Commun; 2011 Jul 29; 411(2):433-9. PubMed ID: 21749855 [Abstract] [Full Text] [Related]
2. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Strotmeier J, Lee K, Völker AK, Mahrhold S, Zong Y, Zeiser J, Zhou J, Pich A, Bigalke H, Binz T, Rummel A, Jin R. Biochem J; 2010 Oct 15; 431(2):207-16. PubMed ID: 20704566 [Abstract] [Full Text] [Related]
5. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapman ER, Stevens RC. Nature; 2006 Dec 21; 444(7122):1096-100. PubMed ID: 17167418 [Abstract] [Full Text] [Related]
6. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Nakamura K, Kohda T, Umeda K, Yamamoto H, Mukamoto M, Kozaki S. Vet Microbiol; 2010 Jan 06; 140(1-2):147-54. PubMed ID: 19720474 [Abstract] [Full Text] [Related]
9. Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D. Zhang Y, Gardberg AS, Edwards TE, Sankaran B, Robinson H, Varnum SM, Buchko GW. Biochimie; 2013 Jul 06; 95(7):1379-85. PubMed ID: 23523511 [Abstract] [Full Text] [Related]
10. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Strotmeier J, Gu S, Jutzi S, Mahrhold S, Zhou J, Pich A, Eichner T, Bigalke H, Rummel A, Jin R, Binz T. Mol Microbiol; 2011 Jul 06; 81(1):143-56. PubMed ID: 21542861 [Abstract] [Full Text] [Related]
11. Unique ganglioside binding by botulinum neurotoxins C and D-SA. Kroken AR, Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT. FEBS J; 2011 Dec 06; 278(23):4486-96. PubMed ID: 21554541 [Abstract] [Full Text] [Related]
12. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity. Arndt JW, Chai Q, Christian T, Stevens RC. Biochemistry; 2006 Mar 14; 45(10):3255-62. PubMed ID: 16519520 [Abstract] [Full Text] [Related]
18. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species. Nakamura K, Kohda T, Shibata Y, Tsukamoto K, Arimitsu H, Hayashi M, Mukamoto M, Sasakawa N, Kozaki S. Infect Immun; 2012 Aug 21; 80(8):2886-93. PubMed ID: 22665374 [Abstract] [Full Text] [Related]
19. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity. Willjes G, Mahrhold S, Strotmeier J, Eichner T, Rummel A, Binz T. Biochemistry; 2013 Jun 04; 52(22):3930-8. PubMed ID: 23647335 [Abstract] [Full Text] [Related]